CoChat

The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival

Open access
Peters, Brandilyn A., Hayes, Richard B., Goparaju, Chandra, Reid, Christopher, Pass, Harvey I., Ahn, Jiyoung · 2019 · Cancer Epidemiology, Biomarkers & Prevention

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Abstract Background: Human microbiota have many functions that could contribute to cancer initiation and/or progression at local sites, yet the relation of the lung microbiota to lung cancer prognosis has not been studied. Methods: In a pilot study, 16S rRNA gene sequencing was performed on paired lung tumor and remote normal samples from the same lobe/segment in 19 patients with non–small cell lung cancer (NSCLC). We explored associations of tumor or normal tissue microbiome diversity and composition with recurrence-free (RFS) and disease-free survival (DFS), and compared microbiome diversity and composition between paired tumor and normal samples. Results: Higher richness and diversity in normal tissue were associated with reduced RFS (richness P = 0.08, Shannon index P = 0.03) and DFS (richness P = 0.03, Shannon index P = 0.02), as was normal tissue overall microbiome composition (Bray–Curtis P = 0.09 for RFS and P = 0.02 for DFS). In normal tissue, greater abundance of family Koribacteraceae was associated with increased RFS and DFS, whereas greater abundance of families Bacteroidaceae, Lachnospiraceae, and Ruminococcaceae were associated with reduced RFS or DFS (P < 0.05). Tumor tissue diversity and overall composition were not associated with RFS or DFS. Tumor tissue had lower richness and diversity (P ≤ 0.0001) than paired normal tissue, though overall microbiome composition did not differ between the paired samples. Conclusions: We demonstrate, for the first time, a potential relationship between the normal lung microbiota and lung cancer prognosis, which requires confirmation in a larger study. Impact: Definition of bacterial biomarkers of prognosis may lead to improved survival outcomes for patients with lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-18-0966

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. American Cancer Society, 2017, Cancer Facts & Figures 2017

Cited by

See all 188

Metadata

Authors
Peters, B. A., Hayes, R. B., Goparaju, C., Reid, C., Pass, H. I., & Ahn, J.
Affiliations
NYU Langone Health (US)
Corresponding author
Ahn, Jiyoung
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2019-04-01
Volume
28
Issue
4
Pages
731-740
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2912126600
Cited by
180
References
40
Citations by year
2026: 19 · 2025: 23 · 2024: 27 · 2023: 27 · 2022: 36 · 2021: 22 · 2020: 19 · 2019: 6
FWCI
6.86
Type
journal article
Language
en
Open access
Locations
  • Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH NCI (5U01CA111295-07)
  • NCI (R01CA164964)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
Keywords
lung microbiome, non-small cell lung cancer, tumor recurrence, recurrence-free survival, disease-free survival, microbiome diversity, microbiota composition, normal lung tissue, Bacteroidaceae, Lachnospiraceae, Ruminococcaceae, bacterial biomarkers, prognosis
MeSH terms
Aged, Female, Humans, Lung Neoplasms, Male, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival. https://app.cochat.ai/papers/10.1158/1055-9965.epi-18-0966
The paper
Peters, B. A., Hayes, R. B., Goparaju, C., Reid, C., Pass, H. I., & Ahn, J. (2019). The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-18-0966

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.